TJD-AD 2020-006 Disciplinary Decision - Powerlifting

In May 2019 the Brazilian Doping Control Authority (ABCD) has reported an anti-doping rule violation against the powerlifter after his sample tested positive for multiple prohibited substances: Androsterone, Drostanolone, Etiocholanolone, Metandienone, Stanozolol, Testosterone and its Adiols.

After notification the Athlete only submitted an admission to the ABCD. Hereafter he didn't respond to the communications, nor filed a statement in his defence, nor attended the hearing of the Brazilian Sports Justice Anti-Doping Tribunal (TJD-AD).

The Rapporteur finds that the presence of multiple prohibited substances has been established in the Athlete's sample and accordingly that he committed an anti-doping rule violation.

In his submission the Athlete only admitted the violation and failed to demonstrate that the violation was not intentional. Furthermore the Rapporteur determines that there had been substantial delays in the proceedings not attributed to the Athlete.

Therefore the TJD-AD Panel decides to impose a 4 year period of ineligibility on the Athlete, starting on the date over de sample collection, i.e. on 23 February 2019.

Original document

Parameters

Legal Source
National Decisions
Date
11 February 2020
Arbitrator
Barbosa, Daniel Chieriguini
Miranda, Martinho Neves
Nunes, Tatiana Mesquita
Original Source
Brazilian Sports Justice Anti-Doping Tribunal (TJD-AD)
Country
Brazil
Language
Portuguese
ADRV
Adverse Analytical Finding / presence
Legal Terms
Admission
Substantial delay / lapsed time limit
Sport/IFs
Powerlifting (IPF) - International Powerlifting Federation
Other organisations
Autoridade Brasileira de Controle de Dopagem (ABCD) - Brazilian Doping Control Authority
Tribunal de Justiça Desportiva Antidopagem (TJD-AD) - Brazilian Sports Justice Anti-Doping Tribunal
Laboratories
Rio de Janeiro, Brazil: Laboratório Brasileiro de Controle de Dopagem – LBCD – LADETEC / IQ - UFRJ
Doping classes
S1. Anabolic Agents
Substances
3α-hydroxy-5α-androstan-17-one (androsterone)
Drostanolone
Etiocholanolone
Metandienone (17β-hydroxy-17α-methylandrosta-1,4-dien-3-one)
Stanozolol
Testosterone
Document type
Pdf file
Date generated
25 July 2022
Date of last modification
7 November 2022
Category
  • Legal Source
  • Education
  • Science
  • Statistics
  • History
Country & language
  • Country
  • Language
Other filters
  • ADRV
  • Legal Terms
  • Sport/IFs
  • Other organisations
  • Laboratories
  • Analytical aspects
  • Doping classes
  • Substances
  • Medical terms
  • Various
  • Version
  • Document category
  • Document type
Publication period
Origin